ID24184A - Obat untuk perawatan disfungsi ereksi - Google Patents

Obat untuk perawatan disfungsi ereksi

Info

Publication number
ID24184A
ID24184A IDW20000221A ID20000221A ID24184A ID 24184 A ID24184 A ID 24184A ID W20000221 A IDW20000221 A ID W20000221A ID 20000221 A ID20000221 A ID 20000221A ID 24184 A ID24184 A ID 24184A
Authority
ID
Indonesia
Prior art keywords
medicine
disfunctions
effective
treatment
combination
Prior art date
Application number
IDW20000221A
Other languages
English (en)
Inventor
Philippe Gorni
Original Assignee
Real 200 Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Real 200 Ltd filed Critical Real 200 Ltd
Publication of ID24184A publication Critical patent/ID24184A/id

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/475Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10Drugs for genital or sexual disorders; Contraceptives for impotence

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IDW20000221A 1997-07-04 1998-07-06 Obat untuk perawatan disfungsi ereksi ID24184A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9708504A FR2765483B1 (fr) 1997-07-04 1997-07-04 Medicament destine a traiter les dysfonctions erectiles

Publications (1)

Publication Number Publication Date
ID24184A true ID24184A (id) 2000-07-13

Family

ID=9508874

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20000221A ID24184A (id) 1997-07-04 1998-07-06 Obat untuk perawatan disfungsi ereksi

Country Status (17)

Country Link
US (1) US20020155136A1 (id)
EP (1) EP1001775B1 (id)
JP (1) JP2002511875A (id)
KR (1) KR20010021505A (id)
CN (1) CN1261798A (id)
AT (1) ATE212841T1 (id)
AU (1) AU743825B2 (id)
BR (1) BR9810981A (id)
CA (1) CA2295916A1 (id)
DE (1) DE69803773T2 (id)
DK (1) DK1001775T3 (id)
ES (1) ES2172171T3 (id)
FR (1) FR2765483B1 (id)
ID (1) ID24184A (id)
IL (1) IL133443A0 (id)
PT (1) PT1001775E (id)
WO (1) WO1999001132A1 (id)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6323211B1 (en) * 1996-02-02 2001-11-27 Nitromed, Inc. Compositions and methods for treating sexual dysfunctions
US6294517B1 (en) 1996-02-02 2001-09-25 Nitromed, Inc. Compositions and kits comprising alpha-adrenergic receptor antagonists and nitric oxide donors and methods of use
US6469065B1 (en) 1996-02-02 2002-10-22 Nitromed, Inc. Nitrosated and nitrosylated α-adrenergic receptor antagonist, compositions and methods of use
US6472425B1 (en) 1997-10-31 2002-10-29 Nitromed, Inc. Methods for treating female sexual dysfunctions
DE19831263A1 (de) * 1998-07-11 2000-01-13 Lohmann Therapie Syst Lts Darreichungsform
EE05315B1 (et) * 1999-09-03 2010-08-16 Eli Lilly And Company Dapoksetiini v?i selle farmatseutiliselt vastuv?etava soola kasutamine ravimi valmistamiseks, mis on ette n„htud imetajal esineva seksuaalse funktsioonih„ire ravimiseks v?i m?jutamiseks
DK1086695T3 (da) * 1999-09-21 2005-04-25 Enzo Leone Antivirale præparater omfattende yohimbin som aktivt princip
US6565851B2 (en) * 2000-05-26 2003-05-20 Horphag Research Limited Relieving symptoms of erectile dysfunction with proanthocyanidins
KR20010016165A (ko) * 2000-11-16 2001-03-05 정순학 성기능 장애 치료를 위한 피부에 적용하는 제제
ITMI20020990A1 (it) * 2002-05-10 2003-11-10 Indena Spa Formulazioni utili nel trattamento dell'impotenza maschile e femminile
ITMI20020994A1 (it) * 2002-05-10 2003-11-10 Indena Spa Formulazioni utili nel trattamento dell'impotenza maschile e femminile
HUP0401422A2 (en) 2004-07-15 2006-04-28 G Laszlo Meszaros Use of l-arginine as vasoaktive ingredient absorbing through skin for external application
DE102005053241A1 (de) * 2005-11-08 2007-05-16 Schwabe Willmar Gmbh & Co Extrakte aus der Rinde von Corynanthe-Arten und deren Verwendung sowie diese Extrakte enthaltende Arzneimittel, diätetische Lebensmittel und pharmazeutische Zubereitungen
CN111840508A (zh) * 2020-07-17 2020-10-30 北京清大赛尔生物科技有限公司 一种预防及治疗男性性功能障碍的外用制剂及其应用
CN113116905A (zh) * 2021-04-20 2021-07-16 北京天玺宝科技有限公司 一种增强男性性功能并持续改善性功能障碍的组合物及其制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5565466A (en) * 1993-08-13 1996-10-15 Zonagen, Inc. Methods for modulating the human sexual response

Also Published As

Publication number Publication date
FR2765483B1 (fr) 2000-02-04
IL133443A0 (en) 2001-04-30
ATE212841T1 (de) 2002-02-15
AU743825B2 (en) 2002-02-07
CN1261798A (zh) 2000-08-02
PT1001775E (pt) 2002-07-31
US20020155136A1 (en) 2002-10-24
BR9810981A (pt) 2000-08-15
DE69803773D1 (de) 2002-03-21
CA2295916A1 (en) 1999-01-14
KR20010021505A (ko) 2001-03-15
JP2002511875A (ja) 2002-04-16
FR2765483A1 (fr) 1999-01-08
WO1999001132A1 (fr) 1999-01-14
ES2172171T3 (es) 2002-09-16
AU8446798A (en) 1999-01-25
DK1001775T3 (da) 2002-04-29
DE69803773T2 (de) 2002-08-29
EP1001775B1 (fr) 2002-02-06
EP1001775A1 (fr) 2000-05-24

Similar Documents

Publication Publication Date Title
ID24184A (id) Obat untuk perawatan disfungsi ereksi
FI972205A0 (fi) cGmp-PDE:n estäjiä erektiohäiriön hoidossa
MX9504415A (es) Eteres antivirales de isoesteres de sustrato de proteasa de aspartato.
PT1010688E (pt) 2-fenil-1-(3,4-di-hidroxi-5-nitrofenil)-1-etanonas substituidas seu uso no tratamento de algumas perturbacoes do sistema nervoso central e periferico e formulacoes do sistema nervoso central e periferico e formulacoes farmaceuticas que as contem
ES2141208T3 (es) Utilizacion de una cantidad eficaz de sustancias activas para el tratamiento de pieles mixtas.
NZ505742A (en) Compositions containing aminobiguanides with antimicrobial activity used to treat contact lenses
DE69932510D1 (de) Vaskularisierungsinhibitoren
MY138883A (en) Use of asiatic acid for treatment of cencer
SE9701161D0 (sv) New use I
DE69310528D1 (de) Verwendung von parathormone, seinen biologisch aktiven fragmenten oder von verwandten peptiden zur behandlung von schwangerschaft
BR9808221A (pt) Método de tratamento de tumor.
RS50148B (sr) Upotreba docetaksela za lečenje hepatoćelijskog karcinoma
ES2178405T3 (es) Uso de selegilina o de desmetilselegilina para tratar heridas, quemaduras y lesiones cutaneas.
EP1037918A4 (en) METHOD AND COMPOSITIONS FOR INCREASING THE EFFICIENCY OF VACCINALS USING CHEMOKINES
ATE359808T1 (de) Verwendung von sarp-1 zur behandlung und/oder vorbeugung von scleroderma
CY1106702T1 (el) Χρηση ενος συνδυασμου μιας πουρινης και ενος παραγοντα δοτη μονοξειδιου του αζωτου για την προληψη ή την αγωγη γενετησιων δυσλειτουργιων
ATE193206T1 (de) Zusammensetzung zur behandlung oder vorbeugung von herpes
GB9505082D0 (en) Medicament
ATE291425T1 (de) R-eliprodil zur behandlung von glaucoma
DE69426986D1 (de) Behandlung von laminitis
ATE236633T1 (de) Topische verwendung von loperamid zur behandlung mikrobieller infektionen
BR9708037A (pt) Método para o tratamento de abuso de substância
OA09771A (en) Asphodelus composition for increasing white blood cell count.
EP0182569A3 (en) Use of 1,6-dimethyl-4-oxo-1,6,7,8,9a-hexahydro-4h-pyridoû1,2-a¨pyrimidine-3-carboxamide for the prevention and treatment of gastrointestinal damages
PT1313500E (pt) Associacoes de dalfopristina/quinupristina com o cefpirome